Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats

Journal of Oral Rehabilitation

Volumn 33, Issue 8, 2006, Pages 609-618

  Shimazu, C ^a   Hara, T ^a   Kinuta, Y ^a   Moriya, K ^a   Maruo, Y ^a   Hanada, S ^a   Minagi, S ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic proteins; Bone regeneration; Edentulous ridge; Polylactic acid polyglycolic acid copolymer gelatin sponge; Vertical bone augmentation

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; GELATIN SPONGE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; DRUG EFFECT; EDENTULOUSNESS; ELECTRON MICROSCOPY; EVALUATION; JAW; MALE; METHODOLOGY; ORAL SURGERY; OSTEOBLAST; PATHOLOGY; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ALVEOLAR PROCESS; ALVEOLAR RIDGE AUGMENTATION; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; GELATIN SPONGE, ABSORBABLE; JAW, EDENTULOUS; LACTIC ACID; MALE; MICROSCOPY, ELECTRON; OSTEOBLASTS; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745699643     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2005.01593.x     Document Type: Article

References (28)

1. Springfield D. Autograft reconstructions. Orthop Clin N Am. 1996;27:483-492.
2. Silva RV, Camilli JA, Bertran CA, Moreira NH. The use of hydroxyapatite and autogenous cancellous bone grafts to repair bone defects in rats. Int J Oral Maxillofac Surg. 2005;34:178-184.
3. Shaoan W, Anyu C, Zineng Y, Zhanjie H, Yunmao W. Alveolar ridge augmentation with bioactive glass ceramics: a histological study. J Oral Rehabil. 1989;16:229-239.
4. Hürzeler MB, Einsele F, Leupolz M, Schmitz HJ, Strub JR. Bone augmentation using a synthetic bone graft in dogs. J Oral Rehabil. 1994;21:373-382.
5. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-899.
6. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW et al. Novel regulators of bone formation: Molecular clones and activities. Science. 1988;242:1528-1534.
7. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem. 1992;267:20352-20362.
8. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop. 1998;346:26-37.
9. Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocrin Rev. 2000;21:393-411.
10. Tamura S, Kataoka H, Matsui Y, Shionoya Y, Ohno K, Michi KI et al. The effects of transplantation of osteoblastic cells with bone morphogenetic protein (BMP)/carrier complex on bone repair. Bone. 2001;29:169-175.
11. Wang BA, Rosen V, D'alessandro JS, Bauduy M, Cordes P, Harada T et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA. 1990;87:2220-2224.
12. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop MB, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg. 1991;117:1101-1112.
13. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Delivery Rev. 2003;55:1613-1629.
14. Hollinger JO, Leong K. Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials. 1996;17:187-194.
15. Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop. 1999;367(Suppl.):95s-106s.
16. Saitoh H, Takata T, Nikai H, Shintani H, Hyon SH, Ikada Y. Effect of polylactic acid on osteoinductive of demineralized bone: preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein. J Oral Rehabil. 1994;21:431-438.
17. Yokota S, Sonohara S, Yoshida M, Murai M, Shimokawa S, Fujimoto R et al. A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration. Int J Pharm. 2001;223:69-79.
18. Kokubo S, Mochizuki M, Fukushima S, Ito T, Nozaki K, Iwai T et al. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier. Biomaterials. 2004;25:1795-1803.
19. Barboza EP, Caúla, Caúla FO, Souza RO, Neto LG, Sorensen RG et al. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol. 2004;75:702-708.
20. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Mineral Res. 1987;2:595-610.
21. Ripamonti U. The induction of bone in osteogenic composites of bone matrix and porous hydroxyapatite replicas: an experimental study on the baboon (Papio ursinus). J Oral Maxillofac Surg. 1991;49:817-830.
22. Terheyden H, Jepsen S, Möller B, Tuker MM, Rueger DC. Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1. Clin Oral Implants Res. 1999;10:510-521.
23. Murata M, Huang BZ, Shibata T, Imai S, Nagai N, Arisue M. Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Int J Oral Maxillofac Surg. 1999;28:232-237.
24. Choi SH, Kim CK, Cho KS, Huh JS, Sorensen RG, Wozney JM et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol. 2002;73:63-72.
25. Lindholm TS, Gao TJ. Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol. 1993;82:3-12.
26. Eggli PS, Müller W, Schenk RK. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. Clin Orthop. 1988;232:127-138.
27. Kuboki Y, Saito T, Murata M, Takita H, Mizuno M, Inoue M et al. Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation. Connect Tissue Res. 1995;32:219-226.
28. Matin K, Nakamura H, Irie K, Ozawa H, Ejiri S. Impact of recombinant human bone morphogenetic protein-2 on residual ridge resorption after tooth extraction: an experimental study in the rat. Int J Oral Maxillofac Implants. 2001;16:400-411.